Home
About BioSig
Overview
Leadership
Bioelectronic Medicine
Partnerships
Pure EP
Our Solution
Publications
Physician Insights
ViralClear
Our Solution
Leadership
News & Media
Overview
Press Releases
BioSig in the News
Presentations
Events
CEO Blog
Investors
Investor Relations
Overview
News / Events
Press Releases
IR Calendar
Email Alerts
Company Info
Profile
Presentations
Management Team
Contacts
FAQ
Financial Info
Balance Sheet
Income Statement
Cash Flow
Financial Results
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Board of Directors
Board Committees
Governance Documents
Contact
News & Media
News & Media
Overview
Press Releases
BioSig in the News
Presentations
Events
CEO Blog
BioSig in the News
Media Coverage
Westport Company May Hold Key To COVID Anti-Viral Drug
Near ‘Party Zero’ in Westport, firm tackles possible coronavirus cure
With heart surgery device selling, Westport innovator eyes wider relevance
Industry Assessment: A Roundtable of Medtech Executives
Team Up to Advance Bioelectronics
BioSig’s PURE EP System Captures Clear Cardiac Signals in First Clinical Cases
BioSig unlocking future of bioelectronic medicine through signal processing
Emergence of Advanced Electrocardiographic Technologies Show Major Promise for Electrophysiology (EP) Industry
BioSig uplists to small-cap Nasdaq exchange amid cardiac device push
View All Media Coverage News
Video Resources
SumZero Headlines: Ken Londoner on Biotech Solutions in Signal Processing
The Future of Bioelectronic Medicine with Suraj Kapa, M.D.
Nasdaq Spotlight: Interview with Ken Londoner
Ken Londoner interviewed by Christine Corrado for Proactive Investors
Ken Londoner interviewed by Ray Hoffman for CEO Radio-WCBS
BioSig (BSGM) Looking Undervalued with Disruptive Technology in $4B EP Market
Greg Greenberg sits down with Kenneth Londoner, Executive Chairman of BioSig Technologies
BioSig Technologies Inc. (OTCQB: BSGM)
View All Video Resources News
